Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Innovation and Product Development news
(page 35)
9 December 2025
Futerro Submits Permit Applications for Port-Jérôme-sur-Seine Biorefinery
Futerro's biorefinery in Normandy aims to produce bio-based plastics, with support from local authorities, targeting production by early 2029.
9 December 2025
Borouge and Borealis Introduce Recleo: Cost-Effective Recycled Solutions
Recleo offers a global portfolio of recycled polyolefins, enhancing sustainability and compliance with evolving regulations, while ensuring quality and reliability for diverse applications.
9 December 2025
Dow Secures Two Cefic Responsible Care Awards
Dow's STEM initiatives and safety training for diisocyanates earn Cefic awards, highlighting their commitment to education and workplace safety in the chemical industry.
9 December 2025
Lilly's Jaypirca Improves Progression-Free Survival in Treatment-Naïve CLL/SLL
Jaypirca reduced disease progression risk by 80% in CLL/SLL patients, showing promising safety and efficacy in a Phase 3 trial, with fewer adverse events compared to chemoimmunotherapy.
9 December 2025
Lilly Completes Acquisition of Adverum
Lilly's tender offer for Adverum shares expired, with 64% tendered. Acquisition completion expected Dec. 9, 2025. Legal and financial advisors involved.
9 December 2025
Roche's Gazyva Approved by EU for Lupus Nephritis
Gazyva, combined with MMF, shows superior results in treating lupus nephritis, potentially delaying end-stage kidney disease, based on phase II and III studies.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
9 December 2025
Roche Introduces CE-Marked PCR Test for Accurate Vaginitis Diagnosis
The new PCR test improves vaginitis diagnosis by detecting bacteria and yeast, using a single swab for faster, accurate results, enhancing healthcare efficiency.
9 December 2025
Brenntag Secures Two German Sustainability Awards
Brenntag's climate efforts earn German Sustainability and Transformation Awards, highlighting their carbon management, renewable energy use, and CO₂-emission-free site in Austria.
9 December 2025
Johnson & Johnson's Phase 3 Study: TECVAYLI® and DARZALEX FASPRO® Show Promise for Relapsed/Refractory Multiple Myeloma
TECVAYLI® plus DARZALEX FASPRO® reduces disease progression risk by 83% in RRMM patients, showing improved survival and quality of life over standard care.
9 December 2025
Croda Partners with Amino to Enhance Biopharma Capabilities
The partnership boosts global supply of high-purity amino acids for pharmaceuticals, enhancing product development and efficiency in biomanufacturing.
9 December 2025
Borealis and Borouge Introduce Recleo: Cost-Effective Recycled Polyolefins
Recleo offers a global portfolio of recycled polyolefins, enhancing sustainability and meeting regulatory targets with consistent quality and reliable supply.
9 December 2025
Topsoe and Carbon Neutral Fuels Collaborate on e-SAF Project with SOEC Technology
Project Starling in the UK will use SOEC technology to produce 25,000 tons of e-SAF annually, aiming for an 89% emissions reduction. Construction starts in 2028, operations by 2031.
9 December 2025
Asahi Kasei Wins 2025 TSMC Award for PIMEL™ in Advanced Packaging
Award highlights innovation in Advanced Packaging materials, with focus on PIMEL™ and AI applications, as part of Asahi Kasei's strategic plan for 2025–2027.
8 December 2025
Air Products and Yara Negotiate Low-Emission Ammonia Projects Partnership
Projects in the U.S. and Saudi Arabia aim for low-emission ammonia production, with investment decisions by 2026 and completion by 2030.
8 December 2025
Yara Advances US Ammonia Strategy with Air Products Partnership
Yara plans US ammonia projects to boost European competitiveness, aligning with capital policy. Final investment decision expected mid-2026.
8 December 2025
Roche's Lunsumio Shows Promise in Early Lymphoma Treatment
Lunsumio, combined with lenalidomide or Polivy, shows potential in treating relapsed or refractory lymphomas, offering outpatient, chemotherapy-free options.
8 December 2025
Genmab Reports Promising Epcoritamab Data for Richter Transformation Treatment
Epcoritamab shows high response rates and potential as monotherapy and in combination for treating Richter Transformation, with manageable side effects.
8 December 2025
TechnipFMC Delivers 100th Subsea 2.0 Tree to Shell
The 100th Subsea 2.0 tree, made in Malaysia, will be used in the Gulf of America. The platform's modular design reduces lead time and enhances efficiency in subsea operations.
8 December 2025
BASF Launches Low-VOC Catalyst Lupragen N 208
Lupragen N 208, a reactive amine catalyst, reduces VOC emissions in PU foams, meeting strict standards for applications like mattresses and automotive interiors.
8 December 2025
TotalEnergies and NEO NEXT Merge to Form UK's Largest Independent Oil and Gas Producer
TotalEnergies holds 47.5% in NEO NEXT+, enhancing synergies and cash flow with a diverse asset portfolio, producing over 250,000 barrels daily by 2026. Completion expected in H1 2026.
8 December 2025
Evonik Releases EPDs for Building Protection Products
EPDs for PROTECTOSIL® products offer transparency on environmental impact, aiding construction decisions and aligning with future regulatory requirements.
8 December 2025
Boehringer Ingelheim Advances Triple-Agonist Peptide for Obesity Treatment
BI 3034701 shows promise in Phase I for obesity treatment, demonstrating safety and weight loss, advancing to mid-stage development.
8 December 2025
RWE Upgrades Lasbek Wind Farm: Fewer Turbines, Higher Output
Four new turbines replace six old ones, boosting capacity to power 18,000 homes. Rotor blades repurposed for noise barriers. Local municipalities gain €100,000 more annually.
8 December 2025
HydroThane Revamps Leadership to Boost Growth
New leadership aims to enhance partnerships, expand markets, and focus on sustainable projects, leveraging Axens' support and global reach.
8 December 2025
Covestro and Allmed Explore Recycling Artificial Kidney Filters
A study aims to recycle polycarbonate from kidney filters, creating a circular economy model for medical devices with partners in the UK.
7 December 2025
Genmab's Phase 3 Trial Shows EPKINLY + R2 Benefits in Relapsed Follicular Lymphoma
EPKINLY + R2 reduces disease progression risk by 79% in relapsed follicular lymphoma, with a 95% response rate. FDA-approved, it offers a new second-line treatment option.
7 December 2025
Toray Develops Technology for 95% Lithium Recovery from Batteries
New nanofiltration membrane efficiently recovers lithium from used batteries, enhancing recycling and supporting closed-loop systems for electrified vehicles.
6 December 2025
Genmab Reports Epcoritamab Trials Show Remission in DLBCL and FL
Epcoritamab shows high response rates in DLBCL and FL trials, with promising results in elderly patients and manageable side effects.
6 December 2025
Protagonist and Takeda: Rusfertide's Long-Term Efficacy in Polycythemia Vera
Rusfertide shows sustained hematocrit control and reduced phlebotomy need in polycythemia vera over 52 weeks, with a consistent safety profile.
6 December 2025
Johnson & Johnson's CARVYKTI® Shows 2.5-Year Remission in Early Myeloma Treatment
CARVYKTI® offers 80% of standard-risk myeloma patients lasting remission after a single infusion, with improved outcomes when used early.
← Previous
Next →
